SAN DIEGO, April 28, 2020 /PRNewswire/ -- Halozyme
Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update
Conference Call for the first quarter 2020 on Monday, May 11 at 4:30
p.m. ET / 1:30 p.m. PT. Dr.
Helen Torley, president and chief
executive officer, will lead the call. On the same date, Halozyme
will release financial results for the first quarter ended
March 31, 2020 following the close of
trading.
The call will be webcast live through the "Investors" section of
Halozyme's corporate website and a recording will be made available
following the close of the call. To access the webcast and
additional documents related to the call, please visit the
Investors page of www.halozyme.com approximately fifteen minutes
prior to the call to register, download and install any necessary
audio software. The live call may be accessed by dialing (833)
968-2181 (domestic callers) or (825) 312-2108 (international
callers). Callers must enter Conference ID 3199114. A telephone
replay will be available after the call by dialing (800) 585-8367
(domestic callers) or (416) 621-4642 (international callers) using
replay ID number 3199114.
About Halozyme
Halozyme Therapeutics, Inc. is a biopharma technology platform
company that provides innovative and disruptive solutions with the
goal of improving patient experience and outcomes. Our proprietary
enzyme rHuPH20 is used to facilitate the delivery of injected drugs
and fluids. We license our technology to biopharmaceutical
companies to collaboratively develop products that combine our
ENHANZE® drug delivery technology with the
collaborators' proprietary compounds. Halozyme is headquartered in
San Diego. For more information
visit www.halozyme.com.
Contact:
Al
Kildani
Vice President, Investor Relations and Corporate Communications
858-704-8122
ir@halozyme.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/halozyme-to-host-first-quarter-2020-financial-results-webcast-and-conference-call-301048834.html
SOURCE Halozyme Therapeutics, Inc.